🇺🇸 FDA
Patent

US 8357676

Ansamycin formulations and methods of use thereof

granted A61KA61K31/33A61K9/146

Quick answer

US patent 8357676 (Ansamycin formulations and methods of use thereof) held by Infinity Discovery, Inc. expires Mon Jan 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Infinity Discovery, Inc.
Grant date
Tue Jan 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/33, A61K9/146, A61P, A61P35/00